Excalibur Medical Sciences
Excalibur Capital has a dedicated medical science team focused on corporate finance advisory services to private medical science companies making us a pre-eminent corporate finance company in the medical science sector.
As part of Excalibur Group we have a unique position in the medical science sector with an established track record of developing internationally successful businesses. The Excalibur Group has raised over €1 billion of finance for its portfolio companies, has been involved in IPOs for 20 companies and facilitated many successful trade sales to multinational companies.
Our capabilities cover all aspects of corporate finance from deal analysis and due diligence through to mergers & acquisitions, trade sales & IPOs.
We have an unparalleled industry network giving us a unique position in the sector.
Our advisory services cover equity private placement, debt arrangement, royalty securitisation, corporate valuation and offset finance advisory.
